| Product Code: ETC6424056 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bhutan Neurology Clinical Trials Market Overview |
3.1 Bhutan Country Macro Economic Indicators |
3.2 Bhutan Neurology Clinical Trials Market Revenues & Volume, 2021 & 2031F |
3.3 Bhutan Neurology Clinical Trials Market - Industry Life Cycle |
3.4 Bhutan Neurology Clinical Trials Market - Porter's Five Forces |
3.5 Bhutan Neurology Clinical Trials Market Revenues & Volume Share, By Phase, 2021 & 2031F |
3.6 Bhutan Neurology Clinical Trials Market Revenues & Volume Share, By Study Design, 2021 & 2031F |
3.7 Bhutan Neurology Clinical Trials Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Bhutan Neurology Clinical Trials Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Bhutan |
4.2.2 Growing government initiatives to promote clinical trials in neurology |
4.2.3 Rise in healthcare expenditure and investments in research and development in the neurology sector |
4.3 Market Restraints |
4.3.1 Limited availability of skilled professionals and resources for conducting neurology clinical trials in Bhutan |
4.3.2 Stringent regulatory requirements and ethical considerations associated with clinical trials |
4.3.3 Lack of awareness and education among the population about participating in clinical trials |
5 Bhutan Neurology Clinical Trials Market Trends |
6 Bhutan Neurology Clinical Trials Market, By Types |
6.1 Bhutan Neurology Clinical Trials Market, By Phase |
6.1.1 Overview and Analysis |
6.1.2 Bhutan Neurology Clinical Trials Market Revenues & Volume, By Phase, 2021- 2031F |
6.1.3 Bhutan Neurology Clinical Trials Market Revenues & Volume, By Phase I, 2021- 2031F |
6.1.4 Bhutan Neurology Clinical Trials Market Revenues & Volume, By Phase II, 2021- 2031F |
6.1.5 Bhutan Neurology Clinical Trials Market Revenues & Volume, By Phase III, 2021- 2031F |
6.1.6 Bhutan Neurology Clinical Trials Market Revenues & Volume, By Phase IV, 2021- 2031F |
6.2 Bhutan Neurology Clinical Trials Market, By Study Design |
6.2.1 Overview and Analysis |
6.2.2 Bhutan Neurology Clinical Trials Market Revenues & Volume, By Interventional, 2021- 2031F |
6.2.3 Bhutan Neurology Clinical Trials Market Revenues & Volume, By Observational, 2021- 2031F |
6.2.4 Bhutan Neurology Clinical Trials Market Revenues & Volume, By Expanded Access, 2021- 2031F |
6.3 Bhutan Neurology Clinical Trials Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Bhutan Neurology Clinical Trials Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.3.3 Bhutan Neurology Clinical Trials Market Revenues & Volume, By Stroke, 2021- 2031F |
6.3.4 Bhutan Neurology Clinical Trials Market Revenues & Volume, By Alzheimer's Disease (AD), 2021- 2031F |
6.3.5 Bhutan Neurology Clinical Trials Market Revenues & Volume, By Parkinson's Disease (PD), 2021- 2031F |
6.3.6 Bhutan Neurology Clinical Trials Market Revenues & Volume, By Others, 2021- 2031F |
7 Bhutan Neurology Clinical Trials Market Import-Export Trade Statistics |
7.1 Bhutan Neurology Clinical Trials Market Export to Major Countries |
7.2 Bhutan Neurology Clinical Trials Market Imports from Major Countries |
8 Bhutan Neurology Clinical Trials Market Key Performance Indicators |
8.1 Patient recruitment rate for neurology clinical trials |
8.2 Success rate of obtaining regulatory approvals for conducting clinical trials |
8.3 Number of collaborations between research institutions and pharmaceutical companies in the neurology sector |
9 Bhutan Neurology Clinical Trials Market - Opportunity Assessment |
9.1 Bhutan Neurology Clinical Trials Market Opportunity Assessment, By Phase, 2021 & 2031F |
9.2 Bhutan Neurology Clinical Trials Market Opportunity Assessment, By Study Design, 2021 & 2031F |
9.3 Bhutan Neurology Clinical Trials Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Bhutan Neurology Clinical Trials Market - Competitive Landscape |
10.1 Bhutan Neurology Clinical Trials Market Revenue Share, By Companies, 2024 |
10.2 Bhutan Neurology Clinical Trials Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here